PRESS-RELEASE ·Filed Apr 15, 2026
Press release · Earnings
Price Chart
Loading chart...
Executive Summary
Vivos Therapeutics, Inc announced it will report its full-year 2025 results.
Key Facts
- Vivos Therapeutics, Inc announced it will report its full-year 2025 results.
Market Snapshot
Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3274457 |
19 reports for VVOS
100% Hit rate @ T+60 Went positive at some point 6 of 8 best @ T+60▲ +80.62%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 8-K | $0.1347 | awaiting T+60 | — | $0.1280 (−4.97%) |
Oct 19, 2026 8d ago | Press Release | $0.1410 | awaiting T+60 | — | $0.1280 (−9.22%) |
Oct 19, 2026 8d ago | 8-K | $0.1406 | awaiting T+60 | — | $0.1280 (−8.96%) |
Oct 15, 2026 12d ago | 8-K | $0.1428 | awaiting T+60 | — | $0.1280 (−10.36%) |
Oct 15, 2026 12d ago | Press Release | $0.1428 | awaiting T+60 | — | $0.1280 (−10.36%) |
Sep 30, 2026 27d ago | 8-K | $0.1490 | awaiting T+60 | — | $0.1280 (+14.09%) |
Aug 28, 2026 8w ago | Press Release | $0.2249 | awaiting T+60 | — | $0.1280 (−43.09%) |
Aug 21, 2026 9w ago | 8-K | $0.2768 | awaiting T+60 | — | $0.1280 (−53.76%) |
Aug 14, 2026 10w ago | Press Release | $0.3012 | awaiting T+60 | — | $0.1280 (+57.50%) |
Aug 14, 2026 10w ago | Press Release | $0.3433 | awaiting T+60 | — | $0.1280 (−62.71%) |
Showing 10 of 19
US Market Status
Market Closed — Opens Thu (11h 30m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers